Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682316 · ClinicalTrials.gov registry record · Phase 3
Negative Pressure Wound Therapy in Post-Operative Incision Management
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 583
- Enrollment target
NCT02682316: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02682316 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 583 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02682316, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 583 participants
- Enrollment target
Study Summary
The purpose of this study is to compare any good and bad effects of using the Prevena Incision Management System to using the usual standard dry gauze approach. The Prevena Incision Management System is a type of Negative Pressure Wound Therapy (NPWT). NPWT is a portable vacuum device made of a sponge-like foam that is applied over your incision to help draw fluid and debris out after surgery.
Interventions
- OTHER dry gauze
- DEVICE The Prevena Incision Management System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 583 participants |
| Start Date | 2016-02 |
| Est. Completion | 2024-01-25 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02682316
The ClinicalTrials.gov registry entry for NCT02682316 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 583 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which dry gauze is the first listed.
NCT02682316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02682316 about?
NCT02682316 is a clinical study titled "Negative Pressure Wound Therapy in Post-Operative Incision Management". The purpose of this study is to compare any good and bad effects of using the Prevena Incision Management System to using the usual standard dry gauze approach. The Prevena Incision Management System is a type of Negative Pressure Wound Therapy (NPWT). NPWT is a portable vacuum device made of a spon...
What is the current status of trial NCT02682316?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 583 participants. The study started on 2016-02. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT02682316?
The interventions under investigation include: dry gauze (OTHER), The Prevena Incision Management System (DEVICE).
Who is sponsoring clinical trial NCT02682316?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.